Supplemental Methods from Ensartinib (X-396) in ALK-Positive Non–Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study

Authors :: Heather A. Wakelee
Christine M. Lovly
Allison Holzhausen
James J. Gibbons
Chris Liang
Kimberly Harrow
Gary Dukart
Jon P. Gockerman
Joel W. Neal
Liping Du
Jennifer G. Whisenant
Rachel E. Sanborn
Barbara J. Gitlitz
Saiama N. Waqar
Ticiana A. Leal
George R. Blumenschein
Karen L. Reckamp
Jeffrey R. Infante
Leora Horn
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental Methods

Tools